Symbol
| SFRP5
| contributors: mct/npt - updated : 12-09-2016
|
HGNC name
| secreted frizzled-related protein 5
|
HGNC id
| 10779
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
|  
| loss of function
|
in colorectal cancer by hypermethylation | tumoral
|  
|  
| --low
|  
|
by hypermethylation in primary hepatocellular carcinoma (Takagi 2008) | tumoral
|  
|  
| --low
|  
|
by hypermethylation in breast cancer associated with unfavorable prognosis (Veeck 2008) | tumoral
|  
|  
| --low
|  
|
CpG methylation-dependent silencing was frequently seen in gastric cancer(Nojima 2007) | constitutional
|  
|  
| --over
|  
|
inhibited early B-cell differentiation in the bone marrow (BM), resulting in the accumulation of cells with a common lymphoid progenitor (CLP) phenotype | constitutional
|  
|  
| --low
|  
|
in obese children, especially in those with metabolic syndrome (MetS), and negatively correlated with body mass index (BMI) | |
Variant & Polymorphism
|
| |
Candidate gene
| SFRP5 methylation may be a novel DNA-based biomarker potentially useful in clinical breast cancer management (Veeck 2008) |
|
DNA methylation markers of Gastric cancer (GC), which may serve as useful markers that may identify a distinct subset of GC (Kang 2008) |
Marker
| represents a candidate for a mature adipocyte marker gene |
Therapy target
| |
| mice overexpressing Sfrp5 had fewer B-lymphocytes in the peripheral blood and spleen | |
mice that lack functional Sfrp5 were resistant to diet-induced obesity |
|
Sfrp5-deficient mice fed a high-calorie diet developed severe glucose intolerance and hepatic steatosis, and their adipose tissue showed an accumulation of activated macrophages |